Jeroen Hofenk is the current Chief Science Officer at SwiftPharma. Prior to this, they held positions as the Chief Science & Innovation Officer at Perpetuum CropScience and the Chief Science Officer at Asterion Therapeutics. Jeroen also founded Nanox Nutriceuticals and served as the head of molecular biology at Helix Therapeutics.
Jeroen Hofenk has over a decade of experience in the biotech industry. Jeroen holds a PhD in Molecular Biology from Utrecht University. Jeroen has authored multiple scientific papers and patents.
Org chart
Sign up to view 0 direct reports
Get started
Teams
This person is not in any teams
